, Ci-dessous les étapes suivies pour le marquage par immunofluorescent du collagène de type IV (Anti-collagène et anti-IgG) : 1-Lavage avec du PBS (0.01 M

, -Trempage pendant 12h à une température de 4° dans une solution de PBS-Tween (0.01%), du BSA (1%) et d'anticorps anti-collagène IV

, Lavage avec du PBS

, Marquage avec l'anticorps secondaire anti-IgG conjugué avec de la fluorescéine

, La mesure moyenne du TBVf à chaque stade tumoral et pour chaque groupe est présentée dans la figure IV.17. Entre J9 et J12, le TBVf a augmenté de façon significative

, Le TBVf a diminué significativement dans le groupe traité quatre jours après l'injection de Bevacizumab

, Aucun changement statistiquement significatif n'a été observé dans le groupe non traité entre J12 et J16

I. V. Figure, Histogramme du TBVf pour les groupes de souris traitées et non traitées à différents stades de progression tumorale. Les changements significatifs de TBVf sont marqués par des astérisques « *, vol.17

, 01 s -1 et 0,05 ± 0,03 s -1 ), mais le changement n'était pas statistiquement significatif. De même, Concernant le suivi de K model (figure IV.18), nous avons trouvé que ce paramètre avait tendance à augmenter entre J9 et J12 (0,025 ± 0

M. Sarraf, A. T. Perles-barbacaru, M. F. Nissou, B. Van-der-sanden, F. Berger et al., Rapid -Steady -State -T 1 signal modeling during contrast agent extravasation: towards tumor blood volume quantification without requiring the arterial input function, Magnetic Resonance in Medicine, 2015.

T. A. Perles-barbacaru, I. Tropres, M. G. Sarraf, D. Chechin, A. Zaccaria et al., Technical Note: Clinical translation of the Rapid-Steady-State-T 1 MRI method for direct cerebral blood volume quantification, Medical Physics, 2015.

U. Gimenez, A. T. Perles-barbacaru, A. Millet, F. Appaix, M. El-atifi et al., Microscopic DTI accurately identifies early glioma cell migration: correlation with multimodal imaging in a new glioma stem cell model, NMR in Biomedicine, 2016.

M. Sarraf, G. Fares, and H. Lahrech, Follow-up of brain microstructure changes in Glioblastoma human model by multiparametric MRI: the effect of Avastin®. ESMRMB-2016

G. Ferrauto, M. Sarraf, E. D. Gregorio, V. Auboiroux, U. Gimenez et al., Use of Yb-HPDO3A probe for CEST-MRI pH mapping in glioblastoma mouse models

G. Ferrauto, M. Sarraf, E. D. Gregorio, V. Auboiroux, F. Berger et al., Lahrech CEST-MRI pH mapping in glioblastoma mouse models: the use of Yb-HPDO3A probe, 2015.

M. Sarraf, A. T. Perles-barbacaru, F. Berger, and H. Lahrech, Tumor blood volume quantification by RSST 1 -MRI method despite contrast agent leakage and without arterial input function determination

A. T. Perles-barbacaru, M. Sarraf, R. Farion, M. F. Nissou, B. Van-der-sanden et al., Pharmacokinetic model for fractional blood volume quantification with the Rapid Steady State T 1 MRI technique in tumors

G. Ferrauto, M. Sarraf, E. D. Gregorio, U. Gimenez, V. Auboiroux et al., Glioblastoma pH mapping by using Yb-HPDO3A CEST MRI probe. EMIM-2016, Ultrech Pays Bas

N. Khater, C. E. Khoury, M. Sarraf, J. Barouky, D. Nasr et al., Volumetric quality assurance of RapidArc plans for multiple intracranial targets using gel dosimetry, 2016.

M. Sarraf, F. Caraguel, F. Berger, B. Van-der-sanden, and H. Lahrech, Monitoring quantitative tumor blood volume in mouse brain under Bevacizumab by the RSST 1 -MRI method

M. Sarraf, L. Selek, V. Auboiroux, F. Berger, H. Chu-grenoble et al., RSST 1 -MRI method for monitoring quantitative tumor blood volume and vessel permeability in humain glioblastoma implented in mouse brain under Bevacizumab

M. Sarraf, L. Selek, F. Berger, G. Fares, B. Van-der-sanden et al.,

, Sensibilité de la méthode RSST 1 aux variations quantitatives de l'angiogenèse tumorale: suivi de croissance du gliome U87 chez la souris et effet du Bevacizumab. SFRMBM-2015

T. A. Perles-barbacaru, M. Sarraf, R. Farion, M. F. Nissou, B. P. Van-der-sanden et al., Novel pharmacokinetic model for fractional blood volume quantification with the Rapid Steady State T 1 MRI technique in tumors with Gd-DOTA permeable vasculature

M. Australia,

, En pratique et pour une même dose à injecter (0,7mmol/kg), il a été préférable d'injecter un grand volume de Gd-DOTA à faible concentration

, Chez le rat l'administration d'un agent de contraste par voie intraveineuse est moins délicate que chez la souris car le volume total injectable est plus grand

, Le prolongateur utilisé est modifié, le tube PE 10 est remplacé par un tube PE 20 (diamètre interne de 0,38 mm). La seringue d'insuline est remplacée par une seringue sans aiguille (1ml)

, La méthode RSST 1 est appliquée quelques secondes après injection du Gd-DOTA en i.v et pendant une courte durée, de l'ordre d'une minute. La méthode RSST 1 se base sur une injection du Gd-DOTA à forte concentration. 1-Hypothèse 1 : Clairance très faible donc n'est pas pris en compte. 2-Hypothèse 2 : L'échange de l'AC est mené uniquement par l

, Le signal vasculaire est supposé à son maximum et constant pendant la courte durée d'analyse du signal RSST 1 mais la concentration plasmatique est très élevée mais décroît uniquement vers le compartiment extravasculaire, vol.3, 2016.

, Métrologie des faisceaux de traitement TRS 398 & 277, 2017.

, Mise en place et application d'un système d'audit de qualité pour la délivrance de dose en radiothérapie et le suivie du patient, pp.2017-2018

, Mise en place du système de contrôle de qualité, pp.2017-2018

, Lister et organiser les tests de contrôle de qualité des accélérateurs linéaires ainsi qu'optimiser le temps de la realisation de ces contrôles, 2016.

, Contrôle de qualité des appareils de traitement et de diagnostic (i.e. CLINAC & SYNERGY, CT-Scan, IRM, TEP, SPECT, pp.2015-2017

, Mise en place et application du protocole d'assurance qualité "3D end-to-end" en Radiochirurgie par modulation d'intensité des multiples lésions cérébrales, 2015.

R. Dosimétries, . Imrt, . Vmat, . Imrs-(i.e, . Pinnacle et al.,

. Aria-&-mosaique, , pp.2015-2018

, Contrôle de qualité des faisceaux du plan de traitement des patients, 2009.

, Mise en place des séquences d'imagerie IRM (i.e. RSST 1

, REFERENCES Teodora-Adriana PERLES-BARBACARU Medical Doctor PhD in Neuro-Imaging Physics Assistant Professor in Medical Imaging and, p.33

A. E. , Investigations on the Theory of the Brownian Movement, p. p.17. A. Stinson B. 2013. Clinical review : Dotarem, Gadoterate Meglumine, 1956.

C. Adamson, O. O. Kanu, A. I. Mehta, C. Di, N. Lin et al., Glioblastoma multiforme: a review of where we have been and where we are going, Expert Opinion on Investigational Drugs, vol.18, issue.8, pp.1061-1083, 2009.

N. S. Akella, D. B. Twieg, T. Mikkelsen, F. H. Hochberg, S. Grossman et al., Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial, Journal of Magnetic Resonance Imaging, vol.20, issue.6, pp.913-922, 2004.

L. Alexander, Diffusion Tensor Imaging of the Brain, 2007.

M. Allen, M. Bjerke, H. Edlund, S. Nelander, and B. Westermark, Origin of the U87MG glioma cell line: Good news and bad news, Sci Transl Med, vol.8, issue.354, pp.354-357, 2016.

A. 2. De-l'anocef-pour, . Les, and . De-l'adulte,

I. Arganda-carreras, O. S. Sorazano, C. Marabini, R. Carazo, J. M. Ortiz-de-solorzano et al., Consistent and Elastic Registration of Histological Sections Using Vector-Spline Regularization, 2006.

H. J. Aronen, J. Glass, F. S. Pardo, J. W. Belliveau, M. L. Gruber et al., ECHO-PLANAR MR CEREBRAL BLOOD-VOLUME MAPPING OF GLIOMAS -CLINICAL UTILITY, Acta Radiologica, vol.36, issue.5, pp.520-528, 1995.

H. J. Aronen and J. Perkio, Dynamic susceptibility contrast MRI of gliomas, Neuroimaging Clinics of North America, vol.12, issue.4, p.501, 2002.

A. Bagri, L. Berry, B. Gunter, M. Singh, I. Kasman et al., Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy, Clin Cancer Res, vol.16, issue.15, pp.3887-900, 2010.

W. M. Bailey, Fast Fluid Attenuated Inversion Recovery-FLAIR imaging and associated artefacts in Magnetic Resonance Imaging-MRI, 2006.

R. Bammer, Basic principles of diffusion-weighted imaging, Eur J Radiol, vol.45, issue.3, pp.169-84, 2003.

E. L. Barbier, L. Lamalle, and M. Decorps, Methodology of brain perfusion imaging, Journal of Magnetic Resonance Imaging, vol.13, issue.4, pp.496-520, 2001.

E. L. Barbier, K. S. St-lawrence, E. Grillon, A. P. Koretsky, and M. Décorps, A model of blood-brain barrier permeability to water: accounting for blood inflow and longitudinal relaxation effects, Magn Reson Med, vol.47, issue.6, pp.1100-1109, 2002.

D. Barsky, B. Pütz, and K. Schulten, Theory of heterogeneous relaxation in compartmentalized tissues, Magn Reson Med, vol.37, issue.5, pp.666-75, 1997.

R. F. Barth, Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas, J Neurooncol, vol.36, issue.1, pp.91-102, 1998.

J. L. Bas, IRM de perfusion des tumeurs cérébrales, J Radiol, 2006.

J. Bastien, K. A. Mcneill, and H. A. Fine, Molecular Characterizations of Glioblastoma, Targeted Therapy, and Clinical Results to Date, Cancer, vol.121, issue.4, pp.502-516, 2015.

M. Beaumont, B. Lemasson, R. Farion, C. Segebarth, C. Remy et al., Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI, Journal of Cerebral Blood Flow and Metabolism, vol.29, issue.10, pp.1714-1726, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00410316

M. Behroozi, C. Chwiesko, F. Ströckens, M. Sauvage, X. Helluy et al., In vivo measurement of T, Magn Reson Med, vol.79, issue.2, pp.1090-1100, 2018.

A. Belot, P. Grosclaude, N. Bossard, E. Jougla, E. Benhamou et al., Cancer incidence and mortality in France over the period 1980-2005, Revue D Epidemiologie Et De Sante Publique, vol.56, issue.3, pp.159-175, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00538673

P. Benda, J. Lightbody, G. Sato, L. Levine, and W. Sweet, Differentiated rat glial cell strain in tissue culture, Science, vol.161, issue.3839, pp.370-371, 1968.

P. Benda, K. Someda, J. Messer, and W. H. Sweet, Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture, J Neurosurg, vol.34, issue.3, pp.310-333, 1971.

T. Beppu, T. Inoue, Y. Shibata, A. Kurose, H. Arai et al., Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors, J Neurooncol, vol.63, issue.2, pp.109-125, 2003.

T. Beppu, T. Inoue, Y. Shibata, N. Yamada, A. Kurose et al., Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas, Surgical Neurology, vol.63, issue.1, pp.56-61, 2005.

J. Bergonié, Interprétation de quelques résultats de la radiothérapie et essai de fixation d'une technique rationnelle. Comptes-rendus de l'Académie des, Sciences, 1906.

F. Binder-foucard, A. Belot, P. Delafosse, L. Remontet, A. Worinoff et al., Estimation nationale de l'incidence et de la mortalité par cancer en France entre, 1980.

A. Bjornerud and K. E. Emblem, A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI, Journal of Cerebral Blood Flow and Metabolism, vol.30, issue.5, pp.1066-1078, 2010.

A. Bjornerud, A. G. Sorensen, K. Mouridsen, and K. E. Emblem, T-1-and T-2*-dominant extravasation correction in DSC-MRI: Part I-theoretical considerations and implications for assessment of tumor hemodynamic properties, Journal of Cerebral Blood Flow and Metabolism, vol.31, issue.10, pp.2041-2053, 2011.

P. M. Black, MEDICAL PROGRESS -BRAIN-TUMORS .1. New England Journal of Medicine, vol.324, issue.21, pp.1471-1476, 1991.

R. Blankenbecler, LOW-DOSE PRETREATMENT FOR RADIATION THERAPY, Dose-Response, vol.8, issue.4, pp.534-542, 2010.

F. Blomstrand, L. Venance, A. L. Sirén, P. Ezan, E. Hanse et al., Endothelins regulate astrocyte gap junctions in rat hippocampal slices, Eur J Neurosci, vol.19, issue.4, pp.1005-1020, 2004.

. Bm-e, Comparison of cytotoxic and anti-angiogenic treatment responses using functional diffusion maps in FLAIR abnormal regions, Proc Intl Soc Mag Reson Med, 2009.

R. H. Bobo, D. W. Laske, A. Akbasak, P. F. Morrison, R. L. Dedrick et al., CONVECTION-ENHANCED DELIVERY OF MACROMOLECULES IN THE BRAIN, Proceedings of the National Academy of Sciences of the United States of America, vol.91, issue.6, pp.2076-2080, 1994.

D. P. Bottaro and L. A. Liotta, Cancer: Out of air is not out of action, Nature, vol.423, issue.6940, pp.593-598, 2003.

J. L. Boxerman, L. M. Hamberg, B. R. Rosen, and R. M. Weisskoff, MR CONTRAST DUE TO INTRAVASCULAR MAGNETIC-SUSCEPTIBILITY PERTURBATIONS, Magnetic Resonance in Medicine, vol.34, issue.4, pp.555-566, 1995.

A. A. Brandes, A. Tosoni, F. Spagnolli, G. Frezza, M. Leonardi et al., Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology, Neuro-Oncology, vol.10, issue.3, pp.361-367, 2008.

L. Breiman, Random forests, pp.5-32, 2001.

B. Jp and A. F. Hottinger, Nouvelle classification OMS 2016 des gliomes : quels changements ?, Rev Med Suisse, 2017.

J. A. Brunberg, T. L. Chenevert, P. E. Mckeever, D. A. Ross, L. R. Junck et al., In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres, AJNR Am J Neuroradiol, vol.16, issue.2, pp.361-71, 1995.

F. Calamante, Arterial input function in perfusion MRI: A comprehensive review, Progress in Nuclear Magnetic Resonance Spectroscopy, vol.74, pp.1-32, 2013.

F. Calamante, E. Vonken, and M. Van-osch, Contrast agent concentration measurements affecting quantification of bolus-tracking perfusion MRI, Magnetic Resonance in Medicine, vol.58, issue.3, pp.544-553, 2007.

M. Candolfi, J. F. Curtin, W. S. Nichols, A. G. Muhammad, G. D. King et al., Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression, J Neurooncol, vol.85, issue.2, pp.133-181, 2007.

M. Candolfi, J. F. Curtin, W. S. Nichols, A. Muhammad, G. D. King et al., Intracranial glioblastoma models in preclinical neurooncology: neuropathological characterization and tumor progression, Journal of Neuro-Oncology, vol.85, issue.2, pp.133-148, 2007.

Y. Cao, C. I. Tsien, V. Nagesh, L. Junck, T. Haken et al., Clinical investigation survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT, International Journal of Radiation Oncology Biology Physics, vol.64, issue.3, pp.876-885, 2006.

A. Carlsson, O. Persson, J. Ingvarsson, B. Widegren, L. Salford et al., Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients, Proteomics Clinical Applications, vol.4, issue.6-7, pp.591-602, 2010.

P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases, Nature, vol.407, issue.6801, pp.249-257, 2000.

S. Cha, E. A. Knopp, G. Johnson, A. Litt, J. Glass et al., Dynamic contrastenhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin, American Journal of Neuroradiology, vol.21, issue.5, pp.881-890, 2000.

M. C. Chamberlain, BEVACIZUMAB FOR RECURRENT MALIGNANT GLIOMAS: EFFICACY, TOXICITY, AND PATTERNS OF RECURRENCE. Neurology, vol.72, issue.8, pp.772-773, 2009.

A. A. Chan, S. J. Nelson, and . Ieee, Simplified gamma-variate fitting of perfusion curves, 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, vol.1, pp.1067-1070, 2004.

O. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., PHASE III TRIAL OF BEVACIZUMAB ADDED TO STANDARD RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA: MATURE PROGRESSION-FREE SURVIVAL AND PRELIMINARY OVERALL SURVIVAL RESULTS IN AVAGLIO, vol.14, pp.101-101, 2012.

O. L. Chinot, D. R. Macdonald, L. E. Abrey, G. Zahlmann, Y. Kerloeguen et al., Response Assessment Criteria for Glioblastoma: Practical Adaptation and Implementation in Clinical Trials of Antiangiogenic Therapy, Current Neurology and Neuroscience Reports, vol.13, issue.5, 2013.

O. L. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma, New England Journal of Medicine, vol.370, issue.8, pp.709-722, 2014.

A. Claes, G. Gambarota, B. Hamans, O. Van-tellingen, P. Wesseling et al., Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment, Int J Cancer, vol.122, issue.9, pp.1981-1987, 2008.

A. Claes, P. Wesseling, J. Jeuken, C. Maass, A. Heerschap et al., Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization, Molecular Cancer Therapeutics, vol.7, issue.1, pp.71-78, 2008.

P. Cohen, Protein kinases -the major drug targets of the twenty-first century?, Nature Reviews Drug Discovery, vol.1, issue.4, pp.309-315, 2002.

S. P. Davies, H. Reddy, M. Caivano, and P. Cohen, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochemical Journal, vol.351, pp.95-105, 2000.

J. F. De-groot, G. Fuller, A. J. Kumar, Y. Piao, K. Eterovic et al., Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice, Neuro Oncol, vol.12, issue.3, pp.233-275, 2010.

W. Debinski and S. B. Tatter, Convection-enhanced delivery for the treatment of brain tumors, Expert Review of Neurotherapeutics, vol.9, issue.10, pp.1519-1527, 2009.

T. Demerath, C. P. Simon-gabriel, E. Kellner, R. Schwarzwald, T. Lange et al., Mesoscopic imaging of glioblastomas: Are diffusion, perfusion and spectroscopic measures influenced by the radiogenetic phenotype, 2016.

H. E. Devries, J. Kuiper, A. G. Deboer, T. Vanberkel, and D. D. Breimer, The blood-brain barrier in neuroinflammatory diseases, Pharmacological Reviews, vol.49, issue.2, pp.143-155, 1997.

F. G. Dhermain, P. Hau, H. Lanfermann, A. H. Jacobs, and M. Van-den-bent, Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas, Lancet Neurology, vol.9, issue.9, pp.906-920, 2010.

K. M. Donahue, R. M. Weisskoff, and D. Burstein, Water diffusion and exchange as they influence contrast enhancement, Jmri-Journal of Magnetic Resonance Imaging, vol.7, issue.1, pp.102-110, 1997.

. Drexel-university, A compendium of drugs used for laboratory animal anesthesia, analgesia, tranquilization and restraint. Philadelphia: Drexel University IACUC, 2007.

P. Dufour, S. Dufour, A. Castonguay, N. Mccarthy, D. Koninck et al., Microscopie à deux photons pour l'imagerie cellulaire fonctionnelle : avantages et enjeux ou Un photon c'est bien? mais deux c'est mieux !, 2006.

A. Einstein, Investigations on the Theory of the Brownian Movement, p.17, 1956.

B. M. Ellingson, M. G. Malkin, S. D. Rand, J. M. Connelly, C. Quinsey et al., Validation of Functional Diffusion Maps (fDMs) as a Biomarker for Human Glioma Cellularity, Journal of Magnetic Resonance Imaging, vol.31, issue.3, pp.538-548, 2010.

B. M. Ellingson, M. G. Malkin, S. D. Rand, P. S. Laviolette, J. M. Connelly et al., Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas, Journal of Neuro-Oncology, vol.102, issue.1, pp.95-103, 2011.

F. Fellner, K. Holl, P. Held, C. Fellner, R. Schmitt et al., A T1-weighted rapid threedimensional gradient-echo technique (MP-RAGE) in preoperative MRI of intracranial tumours, Neuroradiology, vol.38, issue.3, pp.199-206, 1996.

J. Ferlay, . Si, M. Ervik, R. Dikshit, S. Eser et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase, 2013.

N. Ferrara, K. J. Hillan, H. P. Gerber, and W. Novotny, Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer, Nat Rev Drug Discov, vol.3, issue.5, pp.391-400, 2004.

J. P. Finn and R. R. Edelman, Black-blood and segmented k-space magnetic resonance angiography, Magn Reson Imaging Clin N Am, vol.1, issue.2, pp.349-57, 1993.

J. Fogh, J. M. Fogh, and T. Orfeo, One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice, J Natl Cancer Inst, vol.59, issue.1, pp.221-227, 1977.

J. Folkman, ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE, Nature Medicine, vol.1, issue.1, pp.27-31, 1995.

J. Folkman, M. Bach, J. W. Rowe, F. Davidoff, P. Lambert et al., TUMOR ANGIOGENESIS -THERAPEUTIC IMPLICATIONS, New England Journal of Medicine, vol.285, issue.21, p.1182, 1971.

J. Folkman and D. Hanahan, SWITCH TO THE ANGIOGENIC PHENOTYPE DURING TUMORIGENESIS, Multistage Carcinogenesis, vol.22, pp.339-347, 1992.

E. Fonchy, H. Lahrech, F. , A. Dupeyre, R. Benderbous et al., A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: Kinetic study on a C6 rat glioma model, Journal of Magnetic Resonance Imaging, vol.14, issue.2, pp.97-105, 2001.

J. Frahm and W. Haenicke,

K. Franklin and P. George, The mouse Brain in Stereotaxic Coordinates, Compact, 2008.

S. Gahramanov, L. L. Muldoon, X. Li, and E. A. Neuwelt, Improved Perfusion MR Imaging Assessment of Intracerebral Tumor Blood Volume and Antiangiogenic Therapy Efficacy in a Rat Model with Ferumoxytol, Radiology, vol.261, issue.3, pp.796-804, 2011.

H. Gerber, Pharmacology and Pharmacodynamics of Bevacizumab as Monotherapy or in Combination with Cytotoxic Therapy in Preclinical Studies, Cancer Res, 2005.

H. P. Gerber, J. Kowalski, D. Sherman, D. A. Eberhard, and N. Ferrara, Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor, Cancer Res, vol.60, issue.22, pp.6253-6261, 2000.

E. R. Gerstner, P. J. Chen, P. Y. Wen, R. K. Jain, T. T. Batchelor et al., Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib, Neuro Oncol, vol.12, issue.5, pp.466-72, 2010.

E. R. Gerstner, A. G. Sorensen, R. K. Jain, and T. T. Batchelor, Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas, Current Opinion in Neurology, vol.21, issue.6, pp.728-735, 2008.

U. Gimenez, A. T. Perles-barbacaru, A. Millet, F. Appaix, M. El-atifi et al., Microscopic DTI accurately identifies early glioma cell migration: correlation with multimodal imaging in a new glioma stem cell model, NMR Biomed, vol.29, issue.11, pp.1553-1562, 2016.

M. Glas, B. H. Rath, M. Simon, R. Reinartz, A. Schramme et al., Residual Tumor Cells Are Unique Cellular Targets in Glioblastoma, Annals of Neurology, vol.68, issue.2, pp.264-269, 2010.

A. Gossmann, T. H. Helbich, N. Kuriyama, S. Ostrowitzki, T. Roberts et al., Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme, Journal of Magnetic Resonance Imaging, vol.15, issue.3, pp.233-240, 2002.

B. Grobben, P. P. De-deyn, and H. Slegers, Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion, Cell Tissue Res, vol.310, issue.3, pp.257-70, 2002.

A. Gupta, R. J. Young, S. Karimi, S. Sood, Z. Zhang et al., Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma, AJNR Am J Neuroradiol, vol.32, issue.7, pp.1301-1307, 2011.

A. Haase, SNAPSHOT FLASH MRI -APPLICATIONS TO T1, T2, AND CHEMICAL-SHIFT IMAGING, Magnetic Resonance in Medicine, vol.13, issue.1, pp.77-89, 1990.

J. Hajnal, Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain, J Comput Assist Tomogr, 1992.

D. Hanahan and R. A. Weinberg, The hallmarks of cancer, Cell, vol.100, issue.1, pp.57-70, 2000.

A. K. Heye, R. D. Culling, . Valdés-hernández-mec, M. J. Thrippleton, and J. M. Wardlaw, Assessment of bloodbrain barrier disruption using dynamic contrast-enhanced MRI. A systematic review, Neuroimage Clin, vol.6, pp.262-74, 2014.

D. J. Hicklin and L. M. Ellis, Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis, J Clin Oncol, vol.23, issue.5, pp.1011-1038, 2005.

A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van-oosterom et al., Vascular endothelial growth factor and angiogenesis, Pharmacological Reviews, vol.56, issue.4, pp.549-580, 2004.

H. Li, E. Blot, C. S. , Y. Legrand, and H. Lu, Emergence de la thérapie anti-angiogénique : un pari stratégique dans le traitement du cancer, 1998.

M. Hutterer, E. Hattingen, C. Palm, M. A. Proescholdt, and P. Hau, Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients, Neuro Oncol, vol.17, issue.6, pp.784-800, 2015.

G. Iacob and E. B. Dinca, Current data and strategy in glioblastoma multiforme, Journal of medicine and life, vol.2, issue.4, pp.386-93, 2009.

, Impact sur la qualité de vie, prévention, dépistage, soins, recherche (INCA)

F. M. Iwamoto, K. R. Lamborn, H. I. Robins, M. P. Mehta, S. M. Chang et al., Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma, Neuro-Oncology, vol.12, issue.8, pp.855-861, 2010.

G. Jahng, K. Li, L. Ostergaard, and F. Calamante, Perfusion Magnetic Resonance Imaging: A Comprehensive Update on Principles and Techniques, Korean Journal of Radiology, vol.15, issue.5, pp.554-577, 2014.

K. Jahnke, L. L. Muldoon, C. G. Varallyay, S. J. Lewin, D. F. Kraemer et al., Bevacizumab and carboplatin increase survival and asymptomatic tumor volume in a glioma model, Neuro Oncol, vol.11, issue.2, pp.142-50, 2009.

R. Jain, L. M. Scarpace, S. Ellika, R. Torcuator, L. R. Schultz et al., Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker, Journal of Neuro-Oncology, vol.96, issue.3, pp.423-431, 2010.

R. K. Jain, Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy, Science, vol.307, issue.5706, pp.58-62, 2005.

R. K. Jain, D. Tomaso, E. Duda, D. G. Loeffler, J. S. Sorensen et al., Angiogenesis in brain tumours, Nature Reviews Neuroscience, vol.8, issue.8, pp.610-622, 2007.

A. Jivan, M. A. Horsfield, A. R. Moody, and G. R. Cherryman, Dynamic T-1 measurement using snapshot-FLASH MRI, Journal of Magnetic Resonance, vol.127, issue.1, pp.65-72, 1997.

G. Johnson, S. G. Wetzel, S. Cha, J. Babb, and P. S. Tofts, Measuring blood volume and vascular transfer constant from dynamic, T(2)*-weighted contrast-enhanced MRI, Magn Reson Med, vol.51, issue.5, pp.961-969, 2004.

C. Julien, J. F. Payen, I. Tropres, R. Farion, E. Grillon et al., Assessment of vascular reactivity in rat brain glioma by measuring regional blood volume during graded hypoxic hypoxia, British Journal of Cancer, vol.91, issue.2, pp.374-380, 2004.

L. Ka-loh, G. Buonaccorsi, G. Thompson, J. R. Cain, A. Watkins et al., An improved coverage and spatial resolution-using dual injection dynamic contrast-enhanced (ICE-DICE) MRI: a novel dynamic contrast-enhanced technique for cerebral tumors, Magnetic Resonance in Medicine, vol.68, issue.2, pp.452-62, 2012.

W. S. Kamoun, S. S. Chae, D. A. Lacorre, J. A. Tyrrell, M. Mitre et al., Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks, Nat Methods, vol.7, issue.8, pp.655-60, 2010.

A. Kassner, D. J. Annesley, X. P. Zhu, K. L. Li, I. D. Kamaly-asl et al., Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: A possible marker of vascular tortuosity, Journal of Magnetic Resonance Imaging, vol.11, issue.2, pp.103-113, 2000.

J. C. Kesselheim, A. D. Norden, P. Y. Wen, and S. Joffe, Discontinuing Bevacizumab in Patients with Glioblastoma: An Ethical Analysis, Oncologist, vol.16, issue.10, pp.1435-1439, 2011.

O. Keunen, M. Johansson, A. Oudin, M. Sanzey, S. A. Rahim et al., Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma, Proc Natl Acad Sci U S A, vol.108, issue.9, pp.3749-54, 2011.

P. Kickingereder, F. Sahm, B. Wiestler, M. Roethke, S. Heiland et al., Evaluation of Microvascular Permeability with Dynamic Contrast-Enhanced MRI for the Differentiation of Primary CNS Lymphoma and Glioblastoma: Radio logic-Pathologic Correlation, American Journal of Neuroradiology, vol.35, issue.8, pp.1503-1508, 2014.

K. J. Kim, B. Li, K. Houck, J. Winer, and N. Ferrara, The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies, Growth Factors, vol.7, issue.1, pp.53-64, 1992.

V. G. Kiselev, Transverse relaxation effect of MRI contrast agents: A crucial issue for quantitative measurements of cerebral perfusion, Journal of Magnetic Resonance Imaging, vol.22, issue.6, pp.693-696, 2005.

. Kj-z, Histological typing of tumours of the central nervous system, 1979.

F. Kober, I. Iltis, P. J. Cozzone, and M. Bernard, Myocardial blood flow mapping in mice using highresolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia, Magn Reson Med, vol.53, issue.3, pp.601-607, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02119119

D. Koh and D. J. Collins, Diffusion-weighted MRI in the body: Applications and challenges in oncology, American Journal of Roentgenology, vol.188, issue.6, pp.1622-1635, 2007.

T. N. Kreisl, L. Kim, K. Moore, P. Duic, C. Royce et al., Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma, Journal of Clinical Oncology, vol.27, issue.5, pp.740-745, 2009.

S. Kremer, Imagerie de diffusion : principes et applications cliniques, J Radiol. Kroon, 2007.

Y. T. Kuo, A. H. Herlihy, P. W. So, K. K. Bhakoo, and J. D. Bell, In vivo measurements of T1 relaxation times in mouse brain associated with different modes of systemic administration of manganese chloride, J Magn Reson Imaging, vol.21, issue.4, pp.334-343, 2005.

G. Lamour, Influence de la nanostructuration énergétique des substrats dans l'adhésion et la différenceiation des cellules neuronales modèles PC12, 2010.

K. Lamszus, P. Kunkel, and M. Westphal, Invasion as limitation to anti-angiogenic glioma therapy, Acta neurochirurgica. Supplement, vol.88, pp.169-77, 2003.

C. S. Landis, X. Li, F. W. Telang, J. A. Coderre, P. L. Micca et al., Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange, Magn Reson Med, vol.44, issue.4, pp.563-74, 2000.

D. J. Larkman, J. V. Hajnal, A. H. Herlihy, G. A. Coutts, I. R. Young et al., Use of multicoil arrays for separation of signal from multiple slices simultaneously excited, J Magn Reson Imaging, vol.13, issue.2, pp.313-320, 2001.

H. Larsson, F. Courivaud, E. Rostrup, and A. E. Hansen, Measurement of Brain Perfusion, Blood Volume, and Blood-Brain Barrier Permeability, Using Dynamic Contrast-Enhanced T-1-Weighted MRI at 3 Tesla, Magnetic Resonance in Medicine, vol.62, issue.5, pp.1270-1281, 2009.

H. Larsson, M. Stubgaard, J. L. Frederiksen, M. Jensen, O. Henriksen et al., QUANTITATION OF BLOOD-BRAIN-BARRIER DEFECT BY MAGNETIC-RESONANCE-IMAGING AND GADOLINIUM-DTPA IN PATIENTS WITH MULTIPLE-SCLEROSIS AND BRAIN-TUMORS, Magnetic Resonance in Medicine, vol.16, issue.1, pp.117-131, 1990.

M. Law, R. J. Young, J. S. Babb, N. Peccerelli, S. Chheang et al., Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging, Radiology, vol.247, issue.2, pp.490-498, 2008.

L. Bas, J. F. Grand, S. Krainik, A. Lefournier, V. Tropres et al., Perfusion MR imaging in brain tumors, Journal De Radiologie, vol.87, issue.6, pp.807-821, 2006.

L. Bihan and D. , Looking into the functional architecture of the brain with diffusion MRI, Nat Rev Neurosci, vol.4, issue.6, pp.469-80, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00349696

B. Lemasson, Evaluation de l'IRM multiparamétrique comme indicateur de l'effet de thérapies anti-angiognéniques sur des modèles de gliomes implantés chez le rat, 2010.

B. Lemasson, T. Christen, X. Tizon, R. Farion, N. Fondraz et al., Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects, NMR Biomed, vol.24, issue.5, pp.473-82, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00607949

B. Lemasson, O. Duchamp, E. Barbier, P. Provent, X. Tizon et al., multiparametric MRI characterization of six glioma models-Link to Carmustine Treatment Outcome, 2009.

J. M. Lemée, A. Clavreul, M. Aubry, E. Com, M. De-tayrac et al., Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis, J Neurooncol, vol.122, issue.1, pp.53-61, 2015.

B. Levy, Le système des éphrines dans l'angiogenèse normale et tumorale E-VEGF-IMMUNO-ACTU, 2014.

W. Lin, D. R. Abendschein, A. Celik, R. P. Dolan, R. B. Lauffer et al., Intravascular contrast agent improves magnetic resonance angiography of carotid arteries in minipigs, J Magn Reson Imaging, vol.7, issue.6, pp.963-71, 1997.

J. B. Livramento, C. Weidensteiner, M. I. Prata, P. R. Allegrini, C. F. Geraldes et al., First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity, Contrast Media Mol Imaging, vol.1, issue.1, pp.30-39, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00110260

H. Lu, M. Law, G. Johnson, Y. Ge, P. C. Van-zijl et al., Novel approach to the measurement of absolute cerebral blood volume using vascular-space-occupancy magnetic resonance imaging, Magn Reson Med, vol.54, issue.6, pp.1403-1414, 2005.

S. Lu, D. Ahn, G. Johnson, and S. Cha, Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors, AJNR Am J Neuroradiol, vol.24, issue.5, pp.937-978, 2003.

S. Lu, D. Ahn, G. Johnson, M. Law, D. Zagzag et al., Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: Introduction of the tumor infiltration index, Radiology, vol.232, issue.1, pp.221-228, 2004.

A. K. Lucio-eterovic, Y. Piao, and J. F. De-groot, Mediators of Glioblastoma Resistance and Invasion during Antivascular Endothelial Growth Factor Therapy, Clinical Cancer Research, vol.15, issue.14, pp.4589-4599, 2009.

D. R. Macdonald, T. L. Cascino, S. C. Schold, and J. G. Cairncross, RESPONSE CRITERIA FOR PHASE-II STUDIES OF SUPRATENTORIAL MALIGNANT GLIOMA, Journal of Clinical Oncology, vol.8, issue.7, pp.1277-1280, 1990.

M. S. Mahaley, G. L. Odom, and B. Woodhall, HISTOLOGICAL CHANGES AFTER REGIONAL CHEMOTHERAPY -BRAIN AND FACE TUMORS, Archives of Surgery, vol.87, issue.5, pp.765-774, 1963.

M. R. Mancuso, R. Davis, S. M. Norberg, S. O'brien, B. Sennino et al., Rapid vascular regrowth in tumors after reversal of VEGF inhibition, Journal of Clinical Investigation, vol.116, issue.10, pp.2610-2621, 2006.

F. Mauconduit, Imagerie cérébrale par résonance magnétique du tenseur de diffusion: de la modélisation à l'imagerie 3D haute résolution. Applications et fibre tracking dans un modèle de schizophrénie chez la souris, 2012.

. Mcrobbie, MRI From picture to Proton, 2007.

P. Meier and K. L. Zierler, ON THE THEORY OF THE INDICATOR-DILUTION METHOD FOR MEASUREMENT OF BLOOD FLOW AND VOLUME, Journal of Applied Physiology, vol.6, issue.12, pp.731-744, 1954.

W. Meme, M. Vandecasteele, C. Giaume, and L. Venance, Electrical coupling between hippocampal astrocytes in rat brain slices, Neurosci Res, vol.63, issue.4, pp.236-279, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02149164

B. Mettra, F. Appaix, J. Olesiak-banska, L. Bahers, T. Leung et al., A Fluorescent Polymer Probe with High Selectivity toward Vascular Endothelial Cells for and beyond Noninvasive Two-Photon Intravital Imaging of Brain Vasculature, ACS Appl Mater Interfaces, vol.8, issue.27, pp.17047-59, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01378703

S. Miraux, P. Massot, E. J. Ribot, J. M. Franconi, and E. Thiaudiere, 3D TrueFISP imaging of mouse brain at 4.7T and 9.4T, J Magn Reson Imaging, vol.28, issue.2, pp.497-503, 2008.

. Mk-s, Perfusion imaging with echo-planar imaging. Echo-planar imaging-Theory, technique and application, 1998.

B. A. Moffat, T. L. Chenevert, T. S. Lawrence, C. R. Meyer, T. D. Johnson et al., Functional diffusion map: A noninvasive MR1 biomarker for early stratification of clinical brain tumor response, Proceedings of the National Academy of Sciences of the United States of America, vol.102, issue.15, pp.5524-5529, 2005.

J. J. Moré, The Levenberg-Marquardt algorithm: Implementation and theory, pp.105-116, 2006.

L. L. Muldoon, S. Gahramanov, X. Li, D. J. Marshall, D. F. Kraemer et al., Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models, Neuro-Oncology, vol.13, issue.1, pp.51-60, 2011.

H. Nagasawa and J. B. Little, Induction of sister chromatid exchanges by extremely low doses of alphaparticles, Cancer Res, vol.52, issue.22, pp.6394-6400, 1992.

G. Nagashima, R. Suzuki, H. Hokaku, M. Takahashi, T. Miyo et al., Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma, Surgical Neurology, vol.51, issue.3, pp.292-299, 1999.

A. Narayana, P. Kelly, J. Golfinos, E. Parker, G. Johnson et al., Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival, Journal of Neurosurgery, vol.110, issue.1, pp.173-180, 2009.

E. S. Newlands, M. Stevens, S. R. Wedge, R. T. Wheelhouse, and C. Brock, Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials, Cancer Treatment Reviews, vol.23, issue.1, pp.35-61, 1997.

C. Nieder, Target Volume Definition in Radiation Oncology, p.10, 2015.

G. Noel and R. Guillevin, Delineation of glioblastoma, simplicity to complexity, the contribution of imaging, Cancer Radiotherapie, vol.15, issue.6-7, pp.484-494, 2011.

A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas et al., Bevacizumab for recurrent malignant gliomas -Efficacy, toxicity, and patterns of recurrence, Neurology, vol.70, issue.10, pp.779-787, 2008.

J. O'connor, P. S. Tofts, K. A. Miles, L. M. Parkes, G. Thompson et al., Dynamic contrastenhanced imaging techniques: CT and MRI, British Journal of Radiology, vol.84, pp.112-120, 2011.

T. Ohnishi, P. B. Sher, J. B. Posner, and W. R. Shapiro, Increased capillary permeability in rat brain induced by factors secreted by cultured C6 glioma cells: role in peritumoral brain edema, J Neurooncol, vol.10, issue.1, pp.13-25, 1991.

L. Ostergaard, R. M. Weisskoff, D. A. Chesler, C. Gyldensted, and B. R. Rosen, High resolution measurement of cerebral blood flow using intravascular tracer bolus passages .1. Mathematical approach and statistical analysis, Magnetic Resonance in Medicine, vol.36, issue.5, pp.715-725, 1996.

Q. T. Ostrom, L. Bauchet, F. G. Davis, I. Deltour, J. L. Fisher et al., The epidemiology of glioma in adults: a "state of the science" review, Neuro-Oncology, vol.16, issue.7, pp.896-913, 2014.

M. Paez-ribes, A. E. Hudock, J. Takeda, T. Okuyama, H. Vinals et al., Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis, Cancer Cell, vol.15, issue.3, pp.220-231, 2009.

M. J. Paldino, A. Desjardins, H. S. Friedman, J. J. Vredenburgh, and D. P. Barboriak, A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme, British Journal of Radiology, vol.85, pp.382-389, 1012.

J. Y. Park and M. Garwood, Spin-echo MRI using pi/2 and pi hyperbolic secant pulses, Magn Reson Med, vol.61, issue.1, pp.175-87, 2009.

D. W. Parsons, S. Jones, X. Zhang, J. Lin, R. J. Leary et al., An integrated genomic analysis of human glioblastoma Multiforme, Science, vol.321, issue.5897, pp.1807-1812, 2008.

V. Patil and J. G. , An improved model for describing the contrast bolus in perfusion MRI, Medical Physics, vol.38, issue.12, pp.6380-6383, 2011.

C. S. Patlak, R. G. Blasberg, and J. D. Fenstermacher, GRAPHICAL EVALUATION OF BLOOD-TO-BRAIN TRANSFER CONSTANTS FROM MULTIPLE-TIME UPTAKE DATA, Journal of Cerebral Blood Flow and Metabolism, vol.3, issue.1, pp.1-7, 1983.

E. S. Paulson and K. M. Schmainda, Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors, Radiology, vol.249, issue.2, pp.601-613, 2008.

J. Pauly, D. Nishimura, and A. Macovski, A k-space analysis of small-tip-angle excitation, J Magn Reson, vol.213, issue.2, pp.544-57, 1989.

G. Paxinos and W. Charles, The Rat Brain in Stereotaxic Coordinates, 2007.

J. F. Payen, A. Vath, B. Koenigsberg, V. Bourlier, and M. Decorps, Regional cerebral plasma volume response to carbon dioxide using magnetic resonance imaging, Anesthesiology, vol.88, issue.4, pp.984-92, 1998.

K. R. Pechman, D. L. Donohoe, D. P. Bedekar, S. N. Kurpad, R. G. Hoffmann et al., Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume, Journal of Neuro-Oncology, vol.105, issue.2, pp.233-239, 2011.

K. R. Pechman, D. L. Donohoe, D. P. Bedekar, S. N. Kurpad, and K. M. Schmainda, Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume, Magnetic Resonance in Medicine, vol.68, issue.4, pp.1266-1272, 2012.

S. Pennacchietti, P. Michieli, M. Galluzzo, M. Mazzone, S. Giordano et al., Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene, Cancer Cell, vol.3, issue.4, pp.347-61, 2003.

A. Perles-barbacaru, Magnetic resonance imaging of the cerebral blood volume for the characterization of experimental brain tumor neovascularization, 2007.
URL : https://hal.archives-ouvertes.fr/tel-00564020

A. Perles-barbacaru, Magnetic resonance imaging of the cerebral blood volume for the characterization of experimental brain tumor neovascularization, 2011.
URL : https://hal.archives-ouvertes.fr/tel-00564020

A. Perles-barbacaru, L. Lamalle, E. Barbier, C. Segebarth, and H. Lahrech, Rapid steady state T1 method for cerebral blood volume fraction mapping using SINEREM as contrast agent and a three dimensional projection reconstruction acquisition mode, 2008.

A. T. Perles-barbacaru, F. Berger, and H. Lahrech, Quantitative Rapid Steady State T-1 Magnetic Resonance Imaging for Cerebral Blood Volume Mapping in Mice: Lengthened Measurement Time Window with Intraperitoneal Gd-DOTA Injection, Magnetic Resonance in Medicine, vol.69, issue.5, pp.1451-1456, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00726955

A. T. Perles-barbacaru and H. Lahrech, A new magnetic resonance imaging method for mapping the cerebral blood volume fraction: the rapid steady-state T-1 method, Journal of Cerebral Blood Flow and Metabolism, vol.27, issue.3, pp.618-631, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00381751

A. T. Perles-barbacaru, B. Van-der-sanden, R. Farion, and H. Lahrech, How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging, Journal of Cerebral Blood Flow and Metabolism, vol.32, issue.3, pp.489-501, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00726960

P. Lahrech and H. , Quantitative Mapping of Angiogenesis by Magnetic Resonance Imaging IntechOpen, 2013.

P. Tropres, I. Sarraf, M. G. Chechin, D. Zaccaria, A. Grand et al., Technical Note: Clinical translation of the Rapid-Steady-State-T-1 MRI method for direct cerebral blood volume quantification, Medical Physics, vol.42, issue.11, pp.6369-6375, 2015.

T. A. Perles-barbacaru, D. Procissi, A. V. Demyanenko, and R. E. Jacobs, Quantitative pharmacologic MRI in mice, NMR Biomed, vol.25, issue.4, pp.498-505, 2012.

K. Petrecca, M. Guiot, P. Souhami, and L. , Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma, Journal of Neuro-Oncology, vol.111, issue.1, pp.19-23, 2013.

W. B. Pope, J. R. Young, and B. M. Ellingson, Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy, Current Neurology and Neuroscience Reports, vol.11, issue.3, pp.336-344, 2011.

A. Preda, V. Novikov, M. Moglich, K. Turetschek, D. M. Shames et al., MRI monitoring of avastin (TM) antiangiogenesis therapy using B22956/1, a new blood pool contrast agent, in an experimental model of human cancer, Journal of Magnetic Resonance Imaging, vol.20, issue.5, pp.865-873, 2004.

S. Preibisch, S. Saalfeld, and P. Tomancak, Globally optimal stitching of tiled 3D microscopic image acquisitions, Bioinformatics, vol.25, issue.11, pp.1463-1468, 2009.

L. G. Presta, H. Chen, O. Connor, S. J. Chisholm, V. Meng et al., Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders, Cancer Res, vol.57, issue.20, pp.4593-4602, 1997.

S. J. Price, A. M. Young, W. J. Scotton, J. Ching, L. A. Mohsen et al., Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas, J Magn Reson Imaging, vol.43, issue.2, pp.487-94, 2016.

W. S. Price, Pulsed-field gradient nuclear magnetic resonance as a tool for studying translational diffusion .1. Basic theory, Concepts in Magnetic Resonance, vol.9, issue.5, pp.299-336, 1997.

J. M. Provenzale, P. Mcgraw, P. Mhatre, A. C. Guo, and D. Delong, Peritumoral brain regions in gliomas and meningiomas: Investigation with isotropic diffusion-weighted MR imaging and diffusiontensor MR imaging, Radiology, vol.232, issue.2, pp.451-460, 2004.

V. Ranpura, S. Hapani, and S. Wu, Treatment-Related Mortality With Bevacizumab in Cancer Patients A Meta-analysis, Jama-Journal of the American Medical Association, vol.305, issue.5, pp.487-494, 2011.

W. Reichardt, D. Hu-lowe, D. Torres, R. Weissleder, and A. Bogdanov, Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model, Neoplasia, vol.7, issue.9, pp.847-853, 2005.

Y. Ren, D. Fleischmann, K. Foygel, L. Molvin, A. M. Lutz et al., Antiangiogenic and Radiation Therapy Early Effects on In Vivo Computed Tomography Perfusion Parameters in Human Colon Cancer Xenografts in Mice, Investigative Radiology, vol.47, issue.1, pp.25-32, 2012.

J. Rieger, O. Bähr, K. Müller, K. Franz, J. Steinbach et al., Bevacizumab-induced diffusionrestricted lesions in malignant glioma patients, J Neurooncol, vol.99, issue.1, pp.49-56, 2010.

J. Rieger, O. Bähr, M. W. Ronellenfitsch, J. Steinbach, and E. Hattingen, Bevacizumab-induced diffusion restriction in patients with glioma: tumor progression or surrogate marker of hypoxia?, J Clin Oncol, vol.28, issue.27, 2010.

M. Rohrer, H. Bauer, J. Mintorovitch, M. Requardt, and H. J. Weinmann, Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths, Investigative Radiology, vol.40, issue.11, pp.715-724, 2005.

B. R. Rosen, J. W. Belliveau, H. J. Aronen, D. Kennedy, B. R. Buchbinder et al., SUSCEPTIBILITY CONTRAST IMAGING OF CEREBRAL BLOOD-VOLUME -HUMAN-EXPERIENCE, Magnetic Resonance in Medicine, vol.22, issue.2, pp.293-299, 1991.

B. R. Rosen, J. W. Belliveau, B. R. Buchbinder, R. C. Mckinstry, L. M. Porkka et al., CONTRAST AGENTS AND CEREBRAL HEMODYNAMICS. Magnetic Resonance in Medicine, vol.19, issue.2, pp.285-292, 1991.

N. Rouach, A. Koulakoff, V. Abudara, K. Willecke, and C. Giaume, Astroglial metabolic networks sustain hippocampal synaptic transmission, Science, vol.322, issue.5907, pp.1551-1556, 2008.
URL : https://hal.archives-ouvertes.fr/hal-02633838

P. Ruiz-ontanon, J. L. Orgaz, B. Aldaz, A. Elosegui-artola, J. Martino et al., Cellular Plasticity Confers Migratory and Invasive Advantages to a Population of Glioblastoma-Initiating Cells that Infiltrate Peritumoral Tissue, Stem Cells, vol.31, issue.6, pp.1075-1085, 2013.

I. Gribbestad, An Introduction to Dynamic Contrast-Enhanced MRI in Oncology, Medical Radiology (Diagnostic Imaging), 2005.

T. Saito, K. Sugiyama, F. Ikawa, F. Yamasaki, M. Ishifuro et al., Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide, World Neurosurg, vol.97, pp.21-26, 2017.

S. Salas, Bevacizumab: A controversial agent against high grade gliomas, JHN Journal, 2011.

F. San-galli, P. Vrignaud, J. Robert, J. M. Coindre, and F. Cohadon, Assessment of the experimental model of transplanted C6 glioblastoma in Wistar rats, J Neurooncol, vol.7, issue.3, pp.299-304, 1989.

M. Sarraf, A. T. Perles-barbacaru, M. F. Nissou, B. Van-der-sanden, F. Berger et al., Rapid-Steady-State-T-1 Signal Modeling during Contrast Agent Extravasation: Toward Tumor Blood Volume Quantification without Requiring the Arterial Input Function, Magnetic Resonance in Medicine, vol.73, issue.3, pp.1005-1014, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01414347

J. Schindelin, I. Arganda-carreras, E. Frise, V. Kaynig, M. Longair et al., Fiji: an open-source platform for biological-image analysis, Nat Methods, vol.9, issue.7, pp.676-82, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-02616466

K. M. Schmainda, Z. Zhang, M. Prah, B. S. Snyder, M. R. Gilbert et al., Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial, Neuro-Oncology, vol.17, issue.8, pp.1148-1156, 2015.

N. O. Schmidt, M. Ziu, G. Carrabba, C. Giussani, L. Bello et al., Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model, Clinical Cancer Research, vol.10, issue.4, pp.1255-1262, 2004.

A. A. Schricker, J. M. Pauly, J. Kurhanewicz, M. G. Swanson, and D. B. Vigneron, Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging, Magn Reson Med, vol.46, issue.6, pp.1079-87, 2001.

V. Schülen, F. Schick, J. Loichat, U. Helber, P. E. Huppert et al., Evaluation of K-space segmented cine sequences for fast functional cardiac imaging, Invest Radiol, vol.31, issue.8, pp.512-534, 1996.

M. Seiz, U. Krafft, C. F. Freyschlag, C. Weiss, K. Schmieder et al., Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution, Journal of Cancer Research and Clinical Oncology, vol.136, issue.11, pp.1691-1695, 2010.

C. Senft, A. Bink, K. Franz, H. Vatter, T. Gasser et al., Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial, Lancet Oncology, vol.12, issue.11, pp.997-1003, 2011.

Y. Serlin, I. Shelef, B. Knyazer, and A. Friedman, Anatomy and physiology of the blood-brain barrier, Semin Cell Dev Biol, vol.38, pp.2-6, 2015.

G. E. Sheline, IMPORTANCE OF DISTINGUISHING TUMOR GRADE IN MALIGNANT GLIOMAS -TREATMENT AND PROGNOSIS, International Journal of Radiation Oncology Biology Physics, vol.1, issue.7-8, pp.781-786, 1976.

J. Sherriff, J. Tamangani, L. Senthil, G. Cruickshank, D. Spooner et al., Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide, British Journal of Radiology, vol.86, 1022.

H. Shu, M. M. Kim, P. C. Chen, F. Furman, C. M. Julin et al., The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression, Proceedings of the National Academy of Sciences of the United States of America, vol.95, issue.24, pp.14453-14458, 1998.

D. Shweiki, A. Itin, D. Soffer, and E. Keshet, VASCULAR ENDOTHELIAL GROWTH-FACTOR INDUCED BY HYPOXIA MAY MEDIATE HYPOXIA-INITIATED ANGIOGENESIS, Nature, vol.359, issue.6398, pp.843-845, 1992.

S. Sinha, M. E. Bastin, I. R. Whittle, and J. M. Wardlaw, Diffusion tensor MR imaging of high-grade cerebral gliomas, American Journal of Neuroradiology, vol.23, issue.4, pp.520-527, 2002.

C. Sommer, Interactive Learning and Segmentation Toolkit, Eighth IEEE International Symposium on Biomedical Imaging (ISBI), pp.230-233, 2011.

A. G. Sorensen, T. T. Batchelor, W. T. Zhang, P. J. Chen, P. Yeo et al., A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients, Cancer Res, vol.69, issue.13, pp.5296-300, 2009.

A. Stadlbauer, O. Ganslandt, R. Buslei, T. Hammen, S. Gruber et al., Gliomas: Histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging, Radiology, vol.240, issue.3, pp.803-810, 2006.

A. Stadlbauer, P. Pichler, M. Karl, S. Brandner, C. Lerch et al., Quantification of serial changes in cerebral blood volume and metabolism in patients with recurrent glioblastoma undergoing antiangiogenic therapy, Eur J Radiol, vol.84, issue.6, pp.1128-1164, 2015.

E. Stejskal, Spin diffusion measurements: Spin echoes in the presence of a time-dependent field gradient, The Journal of Chemical Physics, vol.42, issue.1, pp.288-292, 1965.

T. Strojnik, R. Kavalar, and T. T. Lah, Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains, Anticancer Res, vol.26, issue.4B, pp.2887-900, 2006.

S. L. Stuckey, T. D. Goh, T. Heffernan, and D. Rowan, Hyperintensity in the subarachnoid space on FLAIR MRI, AJR Am J Roentgenol, vol.189, issue.4, pp.913-934, 2007.

W. Stummer, M. J. Van-den-bent, and M. Westphal, Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion, Acta Neurochirurgica, vol.153, issue.6, pp.1211-1218, 2011.

R. Stupp, W. P. Mason, and M. J. Van-den-beuf, Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma, vol.352, pp.949-949, 2005.

Y. Sun, N. O. Schmidt, K. Schmidt, S. Doshi, J. B. Rubin et al., Perfusion MRI of U87 brain tumors in a mouse model, Magn Reson Med, vol.51, issue.5, pp.893-902, 2004.

Y. P. Sun, R. V. Mulkern, K. Schmidt, S. Doshi, M. S. Albert et al., Quantification of water diffusion and relaxation times of human U87 tumors in a mouse model, Nmr in Biomedicine, vol.17, issue.6, pp.399-404, 2004.

J. S. Taylor and W. E. Reddick, Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI, Advanced Drug Delivery Reviews, vol.41, issue.1, pp.91-110, 2000.

E. M. Thompson, E. P. Frenkel, and E. A. Neuwelt, The paradoxical effect of bevacizumab in the therapy of malignant gliomas, Neurology, vol.76, issue.1, pp.87-93, 2011.

P. S. Tofts, Modeling tracer kinetics in dynamic Gd-DTPA MR imaging, Jmri-Journal of Magnetic Resonance Imaging, vol.7, issue.1, pp.91-101, 1997.

P. S. Tofts, P. S. Tofts, G. Brix, D. L. Buckley, J. L. Evelhoch et al., Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols, T1-weighted DCE Imaging Concepts: Modelling, Acquisition and Analysis, vol.10, pp.223-232, 1999.

R. A. Towner, Assessment of Rodent Glioma Models Using Magnetic Resonance Imaging Techniques, 2011.

A. Tropine, G. Vucurevic, P. Delani, S. Boor, N. Hopf et al., Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas, Journal of Magnetic Resonance Imaging, vol.20, issue.6, pp.905-912, 2004.

I. Tropres, L. Lamalle, M. Peoc'h, R. Farion, Y. Usson et al., In vivo assessment of tumoral angiogenesis, Magnetic Resonance in Medicine, vol.51, issue.3, pp.533-541, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00192515

S. E. Ungersma, G. Pacheco, C. Ho, S. F. Yee, J. Ross et al., Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis, Magn Reson Med, vol.63, issue.6, pp.1637-1684, 2010.

G. Urgoiti, A. D. Singh, and J. C. Easaw, Extended adjuvant temozolomide for treatment of newly diagnosed glioblastoma multiforme, Journal of Neuro-Oncology, vol.108, issue.1, pp.173-177, 2012.

S. Valable, B. Lemasson, R. Farion, M. Beaumont, C. Segebarth et al., Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study, NMR Biomed, vol.21, issue.10, pp.1043-56, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00381408

B. Van-der-sanden, P. Rijken, A. Heerschap, H. Bernsen, and A. Van-der-kogel, In vivo 31P magnetic resonance spectroscopy and morphometric analysis of the perfused vascular architecture of human glioma xenografts in nude mice, 1997.

M. Van-osch, E. Vonken, C. Bakker, and M. A. Viergever, Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI, Magnetic Resonance in Medicine, vol.45, issue.3, pp.477-485, 2001.

C. G. Varallyay, L. L. Muldoon, S. Gahramanov, Y. J. Wu, J. A. Goodman et al., Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model, J Cereb Blood Flow Metab, vol.29, issue.4, pp.853-60, 2009.

S. Verlhac and F. Bernaudin, Place du Doppler transcrânien et de l'imagerie en résonance magnétique dans la drépanocytose, 2008.

M. A. Vogelbaum and M. K. Aghi, Convection-enhanced delivery for the treatment of glioblastoma, Neuro-Oncology, vol.17, pp.3-8, 2015.

J. J. Vredenburgh, A. Desjardins, J. E. Herndon, J. M. Dowel, D. A. Reardon et al., Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma, Clinical Cancer Research, vol.13, issue.4, pp.1253-1259, 2007.

P. Vérant, R. Serduc, B. Van-der-sanden, C. Rémy, and J. C. Vial, A direct method for measuring mouse capillary cortical blood volume using multiphoton laser scanning microscopy, J Cereb Blood Flow Metab, vol.27, issue.5, pp.1072-81, 2007.

W. Wang, W. Sivakumar, S. Torres, N. Jhaveri, V. P. Vaikari et al., Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals, Neurosurgical Focus, vol.38, issue.3, 2015.

S. M. Weis and D. A. Cheresh, Tumor angiogenesis: molecular pathways and therapeutic targets, Nature Medicine, vol.17, issue.11, pp.1359-1370, 2011.

P. Y. Wen, D. R. Macdonald, D. A. Reardon, T. F. Cloughesy, A. G. Sorensen et al., Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group, Journal of Clinical Oncology, vol.28, issue.11, pp.1963-1972, 2010.

U. C. Wieshmann, C. A. Clark, M. R. Symms, F. Franconi, G. J. Barker et al., Reduced anisotropy of water diffusion in structural cerebral abnormalities demonstrated with diffusion tensor imaging, Magn Reson Imaging, vol.17, issue.9, pp.1269-74, 1999.

N. Wilking and B. Jonsson, A pan-European comparison regarding patient access to cancer drugs, 2005.

F. Winkler, S. V. Kozin, R. T. Tong, S. S. Chae, M. F. Booth et al., Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases, Cancer Cell, vol.6, issue.6, pp.553-63, 2004.

J. G. Wolbers, Novel strategies in glioblastoma surgery aim at safe, supra-maximum resection in conjunction with local therapies, Chinese Journal of Cancer, vol.33, issue.1, pp.8-15, 2014.

D. A. Yablonskiy and E. M. Haacke, Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime, Magn Reson Med, vol.32, issue.6, pp.749-63, 1994.

T. Yamahara, Y. Numa, T. Oishi, T. Kawaguchi, T. Seno et al., Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging, Brain Tumor Pathology, vol.27, issue.2, pp.81-87, 2010.

A. D. Yang, T. W. Bauer, E. R. Camp, R. Somcio, W. Liu et al., Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy, Cancer, vol.103, issue.8, pp.1561-70, 2005.

T. P. Yeung, M. Kurdi, Y. Wang, B. Al-khazraji, L. Morrison et al., CT perfusion imaging as an early biomarker of differential response to stereotactic radiosurgery in C6 rat gliomas, PLoS One, vol.9, issue.10, p.109781, 2014.

L. Yu, X. Wu, Z. Cheng, C. V. Lee, J. Lecouter et al., Interaction between bevacizumab and murine VEGF-A: a reassessment, Invest Ophthalmol Vis Sci, vol.49, issue.2, pp.522-529, 2008.

. Yu-s-c, Y. Ping, Y. L. Zhou, Z. Chen, H. Yao et al., Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87, Cancer Letters, vol.265, issue.1, pp.124-134, 2008.

. Yuan-f, Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factoryvascular permeability factor antibody, 1996.

W. Zhang, G. Fulci, J. S. Buhrman, A. O. Stemmer-rachamimov, J. W. Chen et al., Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma, Mol Ther, vol.20, issue.1, pp.37-45, 2012.

Y. Zhang, S. Reckow, C. Webhofer, M. Boehme, P. Gormanns et al., Proteome Scale Turnover Analysis in Live Animals Using Stable Isotope Metabolic Labeling, Analytical Chemistry, vol.83, issue.5, pp.1665-1672, 2011.

H. Zhao, C. Tang, K. Cui, B. T. Ang, and S. T. Wong, A screening platform for glioma growth and invasion using bioluminescence imaging. Laboratory investigation, J Neurosurg, vol.111, issue.2, pp.238-284, 2009.

X. Zhu, S. Wu, W. L. Dahut, and C. R. Parikh, Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis, American Journal of Kidney Diseases, vol.49, issue.2, pp.186-193, 2007.

R. M. Zuniga, R. Torcuator, R. Jain, J. Anderson, T. Doyle et al., Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan, J Neurooncol, vol.91, issue.3, pp.329-365, 2009.